Traduction de «Programme à frais recouvrables du MDN » (Français → Anglais) :

3. Capitalised management costs and fees to be paid after the eligibility period for a financial instrument providing equity shall not exceed 1,5 % per annum of the programme contributions paid to the final recipients within the meaning of Article 42(1)(a) of Regulation (EU) No 1303/2013 in the form of equity, which have yet to be paid back to the financial instrument, calculated pro rata temporis from the end of the eligibility period until repayment of the investment, the end of the recovery procedure in the case of defaults or the period referred to in Article 42(2) of that Regulation, whichever is earlier.

(Return tabled) Question No. 1353 Mr. Kevin Lamoureux: With regard to the Department of National Defence (DND): (a) what are the ranks of each Canadian Armed Forces member and classification of each DND employee who, on December 31, 2012, attended post-graduate training at public expense at a Canadian or international educational institution; and (b) for each, what is (i) the actual yearly salary of the student, (ii) the program of study, (iii) the number of semesters of study paid for by the government since the start of their career, (iv) all the institutions attended, (v) the total cost of tuition paid with respect to the student’s t ...[+++]raining, (vi) whether relocation costs were paid with respect to the training and the amount of those costs, (vii) any other associated costs?

Second, we're updating our cost recovery regime in the health products and food branch to ensure that the department recovers a reasonable portion of its costs for regulatory programs in the branch, including overhead costs.

Accordingly, under these circumstances, the Commission finds that the amount of the benefit to Hynix could not exceed the full amount of the funds obtained by Hynix as a result of the operation of the KDB debenture programme, plus compound interest and the costs of recovery or attempted recovery in the event of default.

Cost-recovery programs currently exist across the health portfolio, including within HPFB, and these include: the therapeutics products directorate, the biologics and genetic therapies directorate, the medical devices directorate, and the food and veterinary drugs programs.

Mr. Jayson Myers: If a cost-recovery program or a fee comes forward, where that cost-recovery program does not have an effective link between fee and service, where it does not have an effective dispute settlement system, where it's not following the guideline effectively or it's not within Treasury Board policy, and where issues are raised that there is not any clearly spelled out private benefit, then I think you could then argue that it is, in effect, a tax.